Literature DB >> 6733355

A parametric study of the effects of the noradrenaline neurotoxin DSP4 on avoidance acquisition and noradrenaline neurones in the CNS of the rat.

T Archer, G Jonsson, S B Ross.   

Abstract

The effects of various doses of DSP4 on two-way active avoidance acquisition in rats and on central noradrenaline neurones were compared. Doses of DSP4 from 3 mg kg-1 i.p. and upwards injected one week before the onset of the avoidance trials significantly impaired two-way avoidance learning. The learning impairment caused by DSP4 (50 mg kg-1 i.p.) lasted for at least 10 weeks. Desipramine (20 mg kg-1) injected either 30 or 60 min before DSP4 (50 mg kg-1) antagonized the active avoidance impairment. A high dose of DSP4 (50 mg kg-1 i.p.) produced profound decreases in dopamine-beta-hydroxylase activity in the frontal cortex and in the concentrations of noradrenaline in various brain regions indicating degeneration of the locus coeruleus noradrenaline system. Low doses of DSP4 (3 and 6 mg kg-1 i.p.) produced small but significant decrease in the concentrations of noradrenaline (NA) in some regions, e.g. cerebral cortex, hippocampus, olfactory bulb and spinal cord. The avoidance impairment caused by the low dose of DSP4 (3 mg kg-1) was absent when rats were tested 10 weeks after treatment nor was NA depletion present when NA was analysed 3 months after treatment.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6733355      PMCID: PMC1987247          DOI: 10.1111/j.1476-5381.1984.tb16465.x

Source DB:  PubMed          Journal:  Br J Pharmacol        ISSN: 0007-1188            Impact factor:   8.739


  22 in total

1.  On the long-lasting inhibitory effect of N-(2-chloroethyl)-N-ethyl-2-bromobenzylamine (DSP 4) on the active uptake of noradrenaline.

Authors:  S B Ross; A L Renyl
Journal:  J Pharm Pharmacol       Date:  1976-05       Impact factor: 3.765

2.  Liquid chromatographic analysis of catecholamines routine assay for regional brain mapping.

Authors:  R Keller; A Oke; I Mefford; R N Adams
Journal:  Life Sci       Date:  1976-10-01       Impact factor: 5.037

3.  Pontine tegmental lesions, monoamine neurons and varieties of learning.

Authors:  T J Crow; A Longden; A Smith; S Wendlandt
Journal:  Behav Biol       Date:  1977-06

4.  Regional changes in [3H]-noradrenaline uptake, catecholamines and catecholamine synthetic and catabolic enzymes in rat brain following neonatal 6-hydroxydopamine treatment.

Authors:  G Jonsson; C Sachs
Journal:  Med Biol       Date:  1976-08

5.  DSP-4: a novel compound with neurotoxic effects on noradrenergic neurons of adult and developing rats.

Authors:  G Jaim-Etcheverry; L M Zieher
Journal:  Brain Res       Date:  1980-04-28       Impact factor: 3.252

6.  Adrenal steroids affect the norepinephrine-sensitive adenylate cyclase system in the rat limbic forebrain.

Authors:  P L Mobley; F Sulser
Journal:  Eur J Pharmacol       Date:  1980-07-25       Impact factor: 4.432

7.  Selective depletion of spinal noradrenaline abolishes post-decapitation convulsions.

Authors:  D C Roberts; S T Mason; H C Fibiger
Journal:  Life Sci       Date:  1978-12-11       Impact factor: 5.037

8.  Long-term effects of N-2-chlorethyl-N-ethyl-2-bromobenzylamine hydrochloride on noradrenergic neurones in the rat brain and heart.

Authors:  S B Ross
Journal:  Br J Pharmacol       Date:  1976-12       Impact factor: 8.739

9.  Noradrenaline and avoidance learning in the rat.

Authors:  S T Mason; H C Fibiger
Journal:  Brain Res       Date:  1979-02-02       Impact factor: 3.252

10.  Physiological function of descending noradrenaline projections to the spinal cord: role in post-decapitation convulsions.

Authors:  S T Mason; H C Fibiger
Journal:  Eur J Pharmacol       Date:  1979-07-15       Impact factor: 4.432

View more
  17 in total

1.  Influence of noradrenaline denervation on MPTP-induced deficits in mice.

Authors:  T Archer; A Fredriksson
Journal:  J Neural Transm (Vienna)       Date:  2005-12-16       Impact factor: 3.575

2.  5-HT agonist induced analgesia modulated by central but not peripheral noradrenaline depletion in rats.

Authors:  B G Minor; T Archer; C Post; G Jonsson; A K Mohammed
Journal:  J Neural Transm       Date:  1986       Impact factor: 3.575

3.  Functional consequences of iron overload in catecholaminergic interactions: the Youdim factor.

Authors:  Trevor Archer; Anders Fredriksson
Journal:  Neurochem Res       Date:  2007-08-12       Impact factor: 3.996

4.  DSP4 alters the effect of d-amphetamine on variable-interval performance: analysis in terms of Herrnstein's equation.

Authors:  M J Morley; C M Bradshaw; E Szabadi
Journal:  Psychopharmacology (Berl)       Date:  1987       Impact factor: 4.530

5.  Postnatal iron overload destroys NA-DA functional interactions.

Authors:  A Fredriksson; T Archer
Journal:  J Neural Transm (Vienna)       Date:  2006-08-24       Impact factor: 3.575

6.  Central noradrenaline depletion antagonizes aspects of d-amphetamine-induced hyperactivity in the rat.

Authors:  T Archer; A Fredriksson; G Jonsson; T Lewander; A K Mohammed; S B Ross; U Söderberg
Journal:  Psychopharmacology (Berl)       Date:  1986       Impact factor: 4.530

7.  Effects of clonidine and alpha-adrenoceptor antagonists on motor activity in DSP4-treated mice II: interactions with apomorphine.

Authors:  A Fredriksson; T Archer
Journal:  Neurotox Res       Date:  2000-04       Impact factor: 3.911

8.  Effects of clonidine and alpha-adrenoceptor antagonists on motor activity in DSP4-treated mice I: dose-, time- and parameter-dependency.

Authors:  T Archer; A Fredriksson
Journal:  Neurotox Res       Date:  2000-04       Impact factor: 3.911

Review 9.  DSP4, a selective neurotoxin for the locus coeruleus noradrenergic system. A review of its mode of action.

Authors:  Svante B Ross; Carina Stenfors
Journal:  Neurotox Res       Date:  2014-06-26       Impact factor: 3.911

10.  Neurotoxic effects of DSP-4 on the central noradrenergic system in male zebra finches.

Authors:  Susanna A Waterman; Cheryl F Harding
Journal:  Behav Brain Res       Date:  2007-11-19       Impact factor: 3.332

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.